Nu Skin Enterprises Inc. (NUS)
NYSE: NUSHealth CareOther PharmaceuticalsUSD
At close: Nov 20, 4:00 PM ET · Delayed 15 min
NUS stock chart
Technical analysisKey statistics
All statistics- Market cap
- $184.98M
- Forward P/E
- 3.36
- EPS (TTM)
- -$4.86
- Dividend yield
- 6.32% ($0.24)
- Ex-dividend date
- Aug 28, 2026
- 52-week range
- 3.75 – 11.67
- Day range
- 3.75 – 3.84
- Volume / Avg
- 794.07K / 533.16K
- Beta
- —
- Shares outstanding
- 48.68M
52-week range
NUS stock today
Shares of Nu Skin Enterprises (NUS) finished higher on Nov 20 at $3.80, a gain of 0.80% or $0.03 per share, versus the S&P 500's 3.70% decline. At this level, NUS sits near the bottom of its 52-week range of $3.75 to $11.67: 67.4% below the high, set on Jan 16, 2026 and 1.3% above the low. NUS is down 60.5% year to date, underperforming the S&P 500 (+1.2%). Over the past 12 months, the stock has lost 62.1%.
Nu Skin Enterprises has posted a net loss over the last twelve months (EPS of -$4.86), so its P/E ratio is not meaningful. Nu Skin Enterprises pays an annual dividend of $0.24 per share, a 6.32% yield at the current price.
Summary generated from market data by MetaCap's automated system. Methodology
About Nu Skin Enterprises
Company profileNu Skin Enterprises, Inc., together with its subsidiaries, engages in the development and distribution of various beauty and wellness products worldwide. It offers skin care devices, cosmetics, and other personal care products, including ageLOC LumiSpa, ageLOC LumiSpa iO, and Nu Skin RenuSpa iO; ageLOC TruFace and ageLOC LumiSpa cleansers and devices; Prysm iO, a data-enabled wellness device; and Nutricentials beauty and Beauty Focus wellness brands. The company also provides wellness products, such as ageLOC TRME, LifePak, and Beauty Focus.
- Sector
- Health Care
- Industry
- Other Pharmaceuticals
- CEO
- Mr. Ryan S. Napierski
- Headquarters
- Provo, UT
- Employees
- 2,800
- IPO year
- 1996
- Website
- nuskin.com
Financial highlights
Full financialsIn fiscal 2025, Nu Skin Enterprises generated $1.49 billion in revenue, down 14.3% from fiscal 2024, its first annual decline since 2024. Net income was $160.2 million, for a net margin of 10.8% versus a median of 4.7% in the prior 5 years. Gross margin was 69.4% (up from 68.2%) and operating margin 4.4%.
| Fiscal year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
| Revenue | $1.49B | $1.73B | $1.97B | $2.23B | $2.70B |
| Growth | -14.26% | -12.04% | -11.53% | -17.44% | +4.41% |
| Net income | $160.20M | $-146.59M | $8.60M | $104.78M | $147.27M |
| EPS (diluted) | $3.18 | $-2.95 | $0.17 | $2.07 | $2.86 |
Analyst forecast
ForecastConsensus
strong_buy
Avg. price target
$12.48+228.42%
Ratings and targets reflect third-party analyst opinions, not MetaCap recommendations.
Earnings
Earnings history- Last reported (Sep/2026)
- Nov 5, 2026
- EPS actual vs est.
- $0.34 vs $0.21
- Surprise
- +61.90%
Dividends
Dividend history- Annual dividend
- $0.24
- Dividend yield
- 6.32%
- Last payment
- $0.06
- Ex-dividend date
- Aug 28, 2026
NUS news
All NUS newsNu Skin Enterprises peers
Health Care sector| Company | Price | % Chg | Market cap | Compare |
|---|---|---|---|---|
| ESYNEnerSyn Global Inc. | 1.11 | -0.89% | $37.44M | vs NUS |
| COSMCosmos Health Inc. | 2.81 | -2.09% | $14.14M | vs NUS |
| MEDSDataMeds AI Inc. | 1.34 | +84.14% | $7.67M | vs NUS |
| HKPDCellyan Biotechnology Co. Ltd Class A | 1.38 | +2.60% | $3.40M | vs NUS |
| HLFHerbalife Ltd. | 15.53 | -0.26% | $1.63B | vs NUS |
| CAHCardinal Health Inc. | 272.81 | +0.17% | $63.06B | vs NUS |
| CORCencora Inc. | 339.09 | -0.63% | $64.71B | vs NUS |
| MCKMcKesson Corporation | 1,069.43 | +0.68% | $123.47B | vs NUS |
Indexes, lists and sector
Nu Skin Enterprises stock FAQ
What is Nu Skin Enterprises's stock price today?
NUS last traded at $3.80 as of Nov 20, 4:00 PM EST, up 0.80% on the day. Prices are delayed at least 15 minutes.
Does Nu Skin Enterprises pay a dividend?
Yes. Nu Skin Enterprises pays $0.24 per share annually, a 6.32% yield. The most recent dividend of $0.06 had an ex-dividend date of Aug 28, 2026.
Who is Nu Skin Enterprises's CEO?
Mr. Ryan S. Napierski is the chief executive officer of Nu Skin Enterprises Inc., which has about 2,800 employees.
What is the NUS 52-week high?
The 52-week high for NUS is $11.67 and the 52-week low is $3.75. The stock is currently 67.4% below its high.